Study of RVT-1401 for the Treatment of Patients With Moderate to Severe Active Graves' Ophthalmopathy (GO)
Clinical trial NCT03922321 · COMPLETED
Trial details
- NCT number
- NCT03922321
- Sponsor
- Immunovant Sciences GmbH
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-22
- Primary completion
- 2020-02-29
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.